Shardul Bal Nagre, MBBS, MPH

Shardul Nagre practices at Holston Valley Medical Center - HOPD in Kingsport, Tennessee.

Shardul Nagre's NPI, 1467771899, was assigned on May 25, 2010. Shardul Nagre holds Tennessee license 53169.

Shardul Nagre's primary practice is Holston Valley Medical Center - HOPD, at 130 W Ravine Rd, Kingsport, TN 37660.

Shardul Nagre's primary practice is Holston Valley Medical Center - HOPD in Kingsport, Tennessee. Shardul Nagre is also affiliated with Holston Valley Medical Center. The medical group on file is Ballad Health Medical Associates Family, Internal & Pediatric Medicine. Dmand AI also links Shardul Nagre to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Shardul Nagre practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Shardul Nagre's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Shardul Nagre is licensed in Tennessee.

CMS data shows 373 Medicare services from Shardul Nagre across 11 procedure codes in 2024, for 274 Medicare patients. Medicare paid $37,139 for them.

CMS counts 274 Medicare patients who saw Shardul Nagre in 2024. The largest group is 75 to 84, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shardul Nagre's median patient age at 74, with 50% women.

In 2024, Shardul Nagre wrote 766 Medicare Part D claims for 173 patients. 93% of them were for generic drugs. CMS names the drug for 709 of them, across 7 drugs with 11 or more claims each, at $48,476 in total drug cost. In 2023, CMS named 631 claims across 8 drugs.

Shardul Nagre accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of leg revascularization (restoring blood flow) by Shardul Nagre, more than 70% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Shardul Nagre, published from 2010 to 2011. Shardul Nagre's most frequent co-authors are Marc A. Passman, Mark A. Patterson and Joseph Anthony Caprini, MD.

Dmand AI links Shardul Nagre to 2 clinical trials. Conditions studied include Carotid Stenosis, Peripheral Arterial Disease and Constriction, Pathologic.

CMS Open Payments shows 223 general payments to Shardul Nagre from 28 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 66% of the total. Medtronic, Inc. paid the most, $8,197.